BioHarvest Sciences Inc. reported Q2 2024 revenue of $6.0M, beat analyst consensus of $6.0M by $57.0K. Diluted EPS came in at $-0.04, beat the $-0.10 consensus by $0.06.
Filings will appear here once submitted to SEC EDGAR.
Common questions about BioHarvest Sciences Inc.'s Q2 2024 earnings report.
BioHarvest Sciences Inc. (BHST) reported Q2 2024 earnings on October 23, 2024 after market close.
BioHarvest Sciences Inc. reported revenue of $6.0M and diluted EPS of $-0.04 for Q2 2024.
Revenue beat the consensus estimate of $6.0M by $57.0K. EPS beat the consensus estimate of $-0.10 by $0.06.